# Mark D. Pegram

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mark-d-pegram/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,970 |
| Field | HER2/EGFR in Cancer Research |
| h-index | 67 |
| i10-index | 169 |
| Last Known Institution | Stanford University |
| OpenAlex ID | https://openalex.org/A5030502460 |
| ORCID iD | https://orcid.org/0000-0002-9743-8118 |
| Works | 421 |

## Researcher papers

- [Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2](https://scholariq.org/papers/use-of-chemotherapy-plus-a-monoclonal-antibody-against-her2-for-metastatic/)
- [Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer](https://scholariq.org/papers/tucatinib-trastuzumab-and-capecitabine-for-her2-positive-metastatic-breast/)
- [Augmented HER-2–Specific Immunity during Treatment with Trastuzumab and Chemotherapy](https://scholariq.org/papers/augmented-her-2-specific-immunity-during-treatment-with-trastuzumab-and/)

## Researcher topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

## Researcher university

- [Stanford University](https://scholariq.org/institutions/stanford-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.